<!doctype html><html><head><meta charset=utf-8><title>Ivermectin taken before COVID decreased death rate by 68 percent (3,000 with Ivermectin vs 3,000 without)</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Ivermectin taken before COVID decreased death rate by 68 percent (3,000 with Ivermectin vs 3,000 without)</h1><time>January 5, 2022</time><div data-pagefind-body><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#ivermectin-prophylaxis-used-for-covid-19-reduces-covid-19-infection-and-mortality-rates-a-city-wide-prospective-observational-study-of-220517-subjects-using-propensity-score-matching>Ivermectin Prophylaxis Used for COVID-19 Reduces COVID-19 Infection and Mortality Rates: A City-Wide, Prospective Observational Study of 220,517 subjects Using Propensity Score Matching.</a></li><li><a href=#ivermectin-factoids>Ivermectin factoids</a></li></ul></li></ul></li></ul></nav><hr><h4 id=ivermectin-prophylaxis-used-for-covid-19-reduces-covid-19-infection-and-mortality-rates-a-city-wide-prospective-observational-study-of-220517-subjects-using-propensity-score-matching>Ivermectin Prophylaxis Used for COVID-19 Reduces COVID-19 Infection and Mortality Rates: A City-Wide, Prospective Observational Study of 220,517 subjects Using Propensity Score Matching.</h4><p>ResearchGate preprint</p><p><strong>Take vs not take Ivermectin 2 days in a row every 15 days in a Brazilian City to prevent serious COVID<br>    dose of 0.2mg/kg/day<br>    7% decrease in infection<br>    56% decrease in hospitalization<br>    68% decrease in death<br>This is not placebo-controlled, but did use Propensity Score Matching<br><a href=/posts/propensity-scores-are-useful-if-there-are-no-hidden-biases>Propensity Scores are useful if there are no hidden biases</a></strong></p><img src=https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/ivermectin-brazil.jpg alt=image width=900><p>Lucy Kerr, MD, ARDMS1, Flavio A. Cadegiani, MD, MSc, PhD2,3, Fernando Baldi,</p><p>PhD4, Raysildo Barbosa Lobo, PhD5, Washington Luiz Olivato Assagra6, Fernando Carlos</p><p>Proeja7, Pierre Kory, MD, MPA3, Jennifer A. Hibberd, DDS, DPD, MRCDC8, Juan J</p><p>Chamie-Quintero9</p><p>9 instituto Kerr de Ensino e Pesquisa, Sao Paulo, Brazil</p><p>2Corpometria Institute, Brasilia, Brazil</p><p>3Front-Line Covid-19 Critical Care Alliance (FLCCC), USA</p><p>4Department of Animal Sciences, State University of Sao Paulo, Sao Paulo, Brazil</p><p>5Department of Genetics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.</p><p>6Centro Técnico de Avalia9ao Genomica C.T.A.G, Ribeirao Preto, Brazil</p><p>7Itajaí City Hall, Itajaí, Brazil</p><p>8University of Toronto, Toronto, Canada</p><p>9Data Analysis, Universidad EAFIT, Cambridge, USA</p><ul><li>Corresponding author Flávio A. Cadegiani, MD, MSc, PhD Corpometria Institute. SGAS 915 Centro Clínico Advance, Rooms 260/262/264, Brasília, DF, Brazil <a href=mailto:f.cadegiani@gmail.com>f.cadegiani@gmail.com</a>, <a href=mailto:flavio.cadegiani@unifesp.br>flavio.cadegiani@unifesp.br</a>, <a href=mailto:flavio@flccc.net>flavio@flccc.net</a> 55 61 981.395.395</li></ul><p>Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both COVID-19 infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in prophylaxis combined with the known safety profile of ivermectin, a citywide prevention program using ivermectin for COVID-19 was implemented in Itajai, a Southern city in Brazil in the state of Santa Catarina. The objective of this study was to evaluate the impact of regular ivermectin use on subsequent COVID-19 infection and mortality rates.</p><p>Materials and methods: We analyzed data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program which occurred between July 2020 to December of 2020 in Itajai, Brazil. Study design, institutional review board approval, and analysis of registry data occurred after completion of the program. The program consisted of inviting the entire population of Itajai to a medical visit in order to enroll in the program and to compile baseline, personal, demographic and medical information. In the absence of contraindications, ivermectin was offered as an optional treatment to be taken <strong>2 consecutive days every 15 days</strong> at a dose of 0.2mg/kg/day. In cases where a participating citizen of Itajai became ill with COVID-19, they were recommended to not use ivermectin or any other medication in early outpatient treatment. Clinical outcomes of infection, hospitalization, and death were automatically reported and entered into the registry in real time. Study analysis consisted of comparing ivermectin users with non-users using cohorts of infected patients propensity score matched (PSM) by age, sex, and comorbidities. COVID-19 infection and mortality rates were analyzed with and without use of propensity score matching.</p><p>Results: A total of 220,517 subjects were included in the analysis; 133,051 (60.3%) regular ivermectin users and 87,466 (39.7%) non-users. Using PSM, two cohorts of 3,034 subjects suffering COVID-19 infection were compared. The regular use of ivermectin led to a 68% reduction in COVID-19 mortality <span>[25 (0.8%) versus 79 (2.6%) among ivermectin non-users; risk ratio (RR), 0.32; 95% confidence interval (CI), 0.20 - 0.49; p &lt; 0.0001]</span>. When adjusted for residual variables, reduction in mortality rate was 70% (RR, 0.30; 95%CI 0.19 - 0.46; p &lt; 0.0001). There was a 56% reduction in hospitalization rate (44 versus 99 hospitalizations among ivermectin users and non-users, respectively; RR, 0.44; 95%CI, 0.31 - 0.63; p &lt; 0.0001). After adjustment for residual variables, reduction in hospitalization rate was 67% (RR, 0.33; 95%CI 023 - 0.66; p &lt; 0.0001).</p><p>{FONT(size=&ldquo;16&rdquo;)} <strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/brazil-prophylacticivermectin.updatedversion.dec242021..pdf>Download the preprint PDF from VitaminDWiki</a></strong> {FONT</p><hr><h4 id=ivermectin-factoids>Ivermectin factoids</h4><ul><li><p>Ivermectin was derived from a microorganism found in soil in Japan.</p></li><li><p>Since it was approved for human use, over 4 billion doses have been administered.</p></li><li><p>Satoshi Omura and William Campbell received a Nobel Prize in 2015 for their discovery and development of ivermectin.</p></li><li><p>Nearly 90 studies, involving over 130,000 patients in 27 countries, have shown statistically significant improvements using ivermectin for prevention and treatment of COVID-19.</p></li></ul></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/ivermectin.html><span class=tag>ivermectin</span></a>
<a href=/tags/life-span.html><span class=tag>life span</span></a>
<a href=/tags/mortality.html><span class=tag>mortality</span></a>
<a href=/tags/mortality.html><span class=tag>Mortality</span></a>
<a href=/tags/virus.html><span class=tag>virus</span></a>
<a href=/tags/virus.html><span class=tag>Virus</span></a></div><div data-pagefind-meta=tags hidden>ivermectin, life span, mortality, Mortality, virus, Virus</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>